These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3907131)

  • 1. [Current trends in the pharmacotherapy of peptic ulcer (a review of the literature)].
    Degtiareva II
    Vrach Delo; 1985 Aug; (8):45-50. PubMed ID: 3907131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current trends in the pharmacotherapy of peptic ulcer (a review of the problem)].
    Burchinskiĭ GI
    Vrach Delo; 1990 May; (5):1-6. PubMed ID: 2204193
    [No Abstract]   [Full Text] [Related]  

  • 3. Peptic ulcer disease.
    Hawker P
    Practitioner; 1989 May; 233(1469):769-70, 773. PubMed ID: 2602318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controversy and trends in ulcer therapy. 1: Treatment of ulcer manifestation].
    Berndt H
    Z Arztl Fortbild (Jena); 1993 Aug; 87(8):635-42. PubMed ID: 8379202
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disquisitions on the medical treatment of ulcer].
    Meeroff M; Cataldi Amatriain R
    Rev Esp Enferm Dig; 1990 Sep; 78(3):159-61. PubMed ID: 2278741
    [No Abstract]   [Full Text] [Related]  

  • 6. [Local factors in the pathogenesis of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1988 May; 66(5):25-30. PubMed ID: 3047490
    [No Abstract]   [Full Text] [Related]  

  • 7. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer].
    Grigor'ev PIa; Isakov VA
    Sov Med; 1991; (3):39-43. PubMed ID: 1909055
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer].
    Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D
    Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug treatment of peptic ulcer syndrome.
    Fielding JF
    Ir Med J; 1982 Oct; 75(10):379-82. PubMed ID: 7174254
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of Alcid V in peptic ulcer therapy].
    Vŭrbanov G; Rusinov E; Danev I; Glinkova V; Panecheva K
    Vutr Boles; 1981; 20(5):27-34. PubMed ID: 7034375
    [No Abstract]   [Full Text] [Related]  

  • 13. [Functional state of the stomach in peptic ulcer in the process of combined treatment].
    Galetskaia TM; Litinskaia EV
    Vrach Delo; 1978 Feb; (2):27-31. PubMed ID: 644994
    [No Abstract]   [Full Text] [Related]  

  • 14. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; tissue healing inducing drugs].
    Mori H; Sato H; Seki Y
    Nihon Rinsho; 1988 Jan; 46(1):50-4. PubMed ID: 3373757
    [No Abstract]   [Full Text] [Related]  

  • 16. Peptic ulcer disease, cytoprotection, and prostaglandins.
    Fiske SC
    Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
    [No Abstract]   [Full Text] [Related]  

  • 17. [The current physiopathological, diagnostic, clinical and therapeutic considerations of peptic ulcer. A comparison between traditional and modern therapeutic methods].
    Pace V; Artico M; Ciccariello M; Bonanni G
    Minerva Dietol Gastroenterol; 1990; 36(2):63-75. PubMed ID: 2247261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problems in the traditional pharmacotherapy and prevention of peptic ulcer].
    Ryss ES
    Ter Arkh; 1984; 56(9):106-10. PubMed ID: 6393409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of mucosal protection of peptic ulceration and its clinical therapeutic application].
    Novis B; Samara M
    Harefuah; 1984 Nov; 107(10):308-10. PubMed ID: 6530177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.